Kidney and Urologic Diseases Statisitics for the U.S.

Kidney Problems

Kidney conditions (infection, kidney stones, cancer, missing kidney, other)
Prevalence (1994): 3.512 million conditions (in civilian noninstitutionalized population)¹
Polycystic kidney disease
Prevalence: Between 1 in 1,000 and 1 in 400 people (closer to latter)²
End-stage renal disease (ESRD)
Prevalence (period, 1993): 257,351 people³*
Resulting from three primary diseases:
Diabetes: 73,681
Hypertension: 63,440
Glomerulonephritis: 41,532
Incidence (new beneficiaries of treatment, 1993): 56,600 people³*
Resulting from these primary diseases**:
Diabetes: 19,013
Hypertension: 15,064
Glomerulonephritis: 5,655
Deaths in treated patients (1993): 40,916 people³*
Amount spent (public and private, 1994): $11.1 billion³*

ESRD treatment:
Use of dialysis (1995): 200,162 people⁴
In-center therapy+:
Hemodialysis: 166,173
IPD: 90
CAPD: 194
CCPD: 114
Home therapy+:
Hemodialysis: 2,086
IPD: 137
CAPD: 21,369
CCPD: 9,999
Number of kidney transplants (by year)⁴:
1995: 11,902
1994: 11,312
1985: 7,695
Number of kidney transplants (by type, 1995)⁴:
From cadaver: 8,486
From living related donor: 2,992
From living unrelated donor: 424
People awaiting transplants (August 31, 1996)⁵: 34,798
Kidney (only): 33,399
Kidney and pancreas: 1,399
Dialysis survival (percent of patients surviving)³*:
1 year (1993): 77.30
2 years (1992-1993): 60.32
5 years (1989-1993): 28.14
10 years (1984-1993): 9.65
Cadaver-donor transplant survival (percent of recipients surviving)³*:
1 year (1993): 93.57
2 years (1992-1993): 90.27
5 years (1989-1993): 78.63
10 years (1984-1993): 55.07
Living-related-donor transplant survival (percent of recipients surviving)³*:
1 year (1993): 97.53
2 years (1992-1993): 95.72
5 years (1989-1993): 89.81
10 years (1984-1993): 77.16

Urologic Problems

Acute urinary conditions (infections of the kidneys and urinary tract, nephrotic syndrome, urethral stricture, cystitis, other)
Incidence (1994): 8.140 million conditions (in civilian noninstitutionalized population)¹
Bladder disorders
Prevalence (1994): 3.747 million disorders (in civilian noninstitutionalized population)¹
Kidney and ureter stones
Doctor visits (1991): 895,467 visits⁶
Cost (total direct and indirect, 1993): $1.83 billion⁷
Hospitalizations (1993): 302,000⁸
Urinary tract infections
Doctor visits (1991): 9.642 million visits⁶
Hospitalizations (1991): 1.547 million⁹
Urinary incontinence
Prevalence: About 13 million adults¹⁰
Interstitial cystitis
Prevalence: About 500,000 people (90 percent of those are women)¹¹

Other Related Problems

Diseases of the prostate
Prevalence (1992): 2.048 million men (in noninstitutionalized population)¹
Enlarged prostate (BPH)
Prevalence:
More than 50 percent of men past age 60;
80 to 90 percent of men past age 80¹²
Hospital discharges for BPH (1993): 375,000 hospitalizations⁸
Prostate cancer
Incidence (1991): 120,000 men develop it each year¹³
Mortality (1991): 30,000 men die of it each year¹³

Impotence/erectile dysfunction

Prevalence: 10 to 15 million men¹⁴

Sources:

1. Current Estimates from the National Health Interview Survey, 1994. National Center for Health Statistics, Centers for Disease Control and Prevention (CDC), U.S. Dept. of Health and Human Services (HHS), December 1995.

2. Torres, V. E., et al. General features of autosomal dominant polycystic kidney disease: Epidemiology. In: Problems in Diagnosis and Management of Polycystic Kidney Disease, Grantham, J. J., and Gardner, K. D., eds. Polycystic Kidney Research Foundation, Kansas City, MO (1985).

3. United States Renal Data System 1996 Annual Data Report, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, HHS, 1996.

4. End Stage Renal Disease Program Highlights 1995 (fact sheet), Health Care Financing Administration, HHS, August 1996.

5. United Network for Organ Sharing. For updates contact the UNOS Data Request Fax Line at (804) 323-3794 or visit the UNOS homepage at http://www.ew3.att.net/unos/.

6. Unpublished data from 1991 National Ambulatory Medical Care Survey (National Center for Health Statistics).

7. Clark, J. Y., et al., Economic impact of urolithiasis in the United States. Journal of Urology, vol. 154, pp. 2020-2024, December 1995.

8. National Hospital Discharge Survey: Annual Summary, 1993, CDC, HHS, 1995.

9. Detailed Diagnoses and Procedures, National Hospital Discharge Survey, 1991, National Center for Health Statistics, CDC, HHS, February 1994.

10. Urinary Incontinence in Adults: Clinical Practice Guideline Update. Agency for Health Care Policy and Research, HHS, 1996.

11. Interstitial Cystitis, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, HHS, 1994.

12. Prostate Enlargement: Benign Prostatic Hyperplasia, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, 1991.

13. Prostate Cancer: What Every Man Over 40 Should Know, Prostate Health Council, c/o American Foundation for Urologic Disease, Inc., Baltimore, MD.

14. Impotence(fact sheet), National Institute of Diabetes and Digestive and Kidney Diseases, NIH, HHS, 1995.

National Kidney and Urologic Diseases Information Clearinghouse

3 Information Way
Bethesda, MD 20892-3580
E-mail: nkudic@aerie.com

The National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, one of the National Institutes of Health, under the U.S. Public Health Service. The clearinghouse, authorized by Congress in 1987, provides information about diseases of the kidneys and urologic system to people with such afflictions and their families, health care professionals, and the public. NKUDIC answers inquiries; develops, reviews, and distributes publications; and works closely with professional and patient organizations and government agencies to coordinate resources about kidney and urologic diseases.

Publications produced by the clearinghouse are reviewed carefully for scientific accuracy, content, and readability. Materials produced by other sources are also reviewed for scientific accuracy and are used, along with clearinghouse publications, to answer inquiries.

This electronic publication is not subject to copyright restrictions. The clearinghouse encourages users of this text to duplicate and distribute as many copies as desired.

Return to Patient Information